Medical Developments Gross Profit vs. Shares Owned By Institutions
| MVP Stock | 0.42 0.01 2.33% |
Gross Profit | First Reported 2002-12-31 | Previous Quarter -5.5 M | Current Value 3 M | Quarterly Volatility 2.8 M |
For Medical Developments profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Medical Developments to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Medical Developments International utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Medical Developments's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Medical Developments International over time as well as its relative position and ranking within its peers.
Medical |
Medical Developments Shares Owned By Institutions vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Medical Developments's current stock value. Our valuation model uses many indicators to compare Medical Developments value to that of its competitors to determine the firm's financial worth. Medical Developments International is considered to be number one stock in gross profit category among its peers. It also is considered to be number one stock in shares owned by institutions category among its peers . The ratio of Gross Profit to Shares Owned By Institutions for Medical Developments International is about 883,462 . At this time, Medical Developments' Gross Profit is comparatively stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medical Developments' earnings, one of the primary drivers of an investment's value.Medical Shares Owned By Institutions vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Medical Developments |
| = | 22.21 M |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Medical Developments |
| = | 25.14 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Medical Shares Owned By Institutions Comparison
Medical Developments is currently under evaluation in shares owned by institutions category among its peers.
Medical Developments Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Medical Developments, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Medical Developments will eventually generate negative long term returns. The profitability progress is the general direction of Medical Developments' change in net profit over the period of time. It can combine multiple indicators of Medical Developments, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 2.9 M | 3 M | |
| Operating Income | -16.9 M | -16 M | |
| Income Before Tax | -32.9 M | -31.3 M | |
| Total Other Income Expense Net | -16.1 M | -15.3 M | |
| Income Tax Expense | 8.1 M | 8.5 M | |
| Net Loss | -5 M | -4.8 M | |
| Net Loss | -41 M | -38.9 M | |
| Net Loss | -41 M | -38.9 M | |
| Net Interest Income | 316 K | 331.8 K | |
| Interest Income | 402 K | 243.6 K | |
| Change To Netincome | -10.9 M | -10.3 M |
Medical Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Medical Developments. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Medical Developments position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Medical Developments' important profitability drivers and their relationship over time.
Use Medical Developments in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medical Developments position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medical Developments will appreciate offsetting losses from the drop in the long position's value.Medical Developments Pair Trading
Medical Developments International Pair Trading Analysis
The ability to find closely correlated positions to Medical Developments could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medical Developments when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medical Developments - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medical Developments International to buy it.
The correlation of Medical Developments is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medical Developments moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medical Developments moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medical Developments can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Medical Developments position
In addition to having Medical Developments in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Computers Thematic Idea Now
Computers
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Computers theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Computers Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Medical Stock Analysis
When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.